Overview
Gaku Takano practices practicing medicine in Nagoya, Japan.
Their clinical expertise encompasses Salivary Gland Tumors, Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Oral Herpes.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gaku Takano
Is Gaku Takano a top-rated expert for Salivary Gland Tumors?
MediFind is an objective health platform that identifies experts based on real-world data. Gaku Takano is classified as an Experienced expert for Salivary Gland Tumors, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gaku Takano participate in research or clinical trials?
Yes. Gaku Takano has published 15 articles and abstracts on conditions like Salivary Gland Tumors. You can view a list of Gaku Takano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Oral HerpesTakano isExperienced. Learn about Oral Herpes.
- Salivary Gland TumorsTakano isExperienced. Learn about Salivary Gland Tumors.
- Tongue CancerTakano isExperienced. Learn about Tongue Cancer.